TV News LIES

Sunday, Mar 29th

Last update11:06:57 PM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


Gynecologist Calls Abortion Reversal Bill 'Downright Offensive'

Doug ducey, arizona governorThe Arizona State Legislature passed a bill on Wednesday that requires doctors to tell women seeking...

The dangerous Medicare loophole of 'observation status'

Medicare loopholeOn the morning of Sept. 23, 2014, Caroline Giada woke up in her home in coastal...

Georgia Governor to sign bill legalizing marijuana derivative

Georgia marijuana billGeorgia's Gov. Nathan Deal is expected to sign a bill legalizing a marijuana derivative after the...

Antibiotic Use On Farms Skyrockets Worldwide

antibiotics used on farmsSorry bacon lovers, we've got some sad news about your favorite meat.  To get those sizzling...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!